Your browser doesn't support javascript.
loading
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.
Ozdarendeli, Aykut; Sezer, Zafer; Pavel, Shaikh Terkis Islam; Inal, Ahmet; Yetiskin, Hazel; Kaplan, Busra; Uygut, Muhammet Ali; Bayram, Adnan; Mazicioglu, Mumtaz; Unuvar, Gamze Kalin; Yuce, Zeynep Ture; Aydin, Gunsu; Aslan, Ahmet Furkan; Kaya, Refika Kamuran; Koc, Rabia Cakir; Ates, Ihsan; Kara, Ates.
Affiliation
  • Ozdarendeli A; Department of Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye; Vaccine Research, Development and Application Centre (ERAGEM), Erciyes University, Kayseri, Turkiye. Electronic address: aozdarendeli@erciyes.edu.tr.
  • Sezer Z; Department of Medical Pharmacology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye; Good Clinical Practise Centre (IKUM), Erciyes University, Kayseri, Turkiye. Electronic address: zsezer@erciyes.edu.tr.
  • Pavel STI; Department of Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye; Vaccine Research, Development and Application Centre (ERAGEM), Erciyes University, Kayseri, Turkiye.
  • Inal A; Department of Medical Pharmacology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye; Good Clinical Practise Centre (IKUM), Erciyes University, Kayseri, Turkiye.
  • Yetiskin H; Department of Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye; Vaccine Research, Development and Application Centre (ERAGEM), Erciyes University, Kayseri, Turkiye.
  • Kaplan B; Department of Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye; Vaccine Research, Development and Application Centre (ERAGEM), Erciyes University, Kayseri, Turkiye.
  • Uygut MA; Vaccine Research, Development and Application Centre (ERAGEM), Erciyes University, Kayseri, Turkiye.
  • Bayram A; Department of Anesthesiology and Reanimation, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.
  • Mazicioglu M; Good Clinical Practise Centre (IKUM), Erciyes University, Kayseri, Turkiye; Department of Family Medicine, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.
  • Unuvar GK; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.
  • Yuce ZT; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.
  • Aydin G; Department of Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye; Vaccine Research, Development and Application Centre (ERAGEM), Erciyes University, Kayseri, Turkiye.
  • Aslan AF; Department of Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye; Vaccine Research, Development and Application Centre (ERAGEM), Erciyes University, Kayseri, Turkiye.
  • Kaya RK; Vaccine Research, Development and Application Centre (ERAGEM), Erciyes University, Kayseri, Turkiye; Health Institutes of Turkiye (TUSEB), Istanbul, Turkiye.
  • Koc RC; Health Institutes of Turkiye (TUSEB), Istanbul, Turkiye; Department of Bioenginering, Faculty of Chemistry-Metallurgy, Yildiz Technical University, Faculty of Bioengineering, Turkiye.
  • Ates I; Department of Internal Medicine, University of Health Sciences Ankara City Hospital, Ankara, Turkiye.
  • Kara A; Hacettepe University, Faculty of Medicine Department of Pediatrics, Pediatric Infectious Diseases, Ankara, Turkiye.
Vaccine ; 41(2): 380-390, 2023 01 09.
Article in En | MEDLINE | ID: mdl-36460536
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Vaccine Year: 2023 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: Vaccine Year: 2023 Document type: Article Country of publication: Netherlands